EUVIMEDAvasta EUVIMED
Open access · CC BY-NC-ND 4.0

Exposure to potentially teratogenic medications before and during the first trimester of pregnancy compared to women of childbearing age: A retrospective analysis of Swiss claims data (2015–2021)

Carole A Marxer iD, Sereina M Graber, Daniel Surbek iD, Alice Panchaud iD, Christoph R Meier iD, Julia Spoendlin iD

Acta Obstetricia et Gynecologica Scandinavica · 2025

DOI: 10.1111/aogs.15052 ↗

At a glance

Journal article in Acta Obstetricia et Gynecologica Scandinavica, 2025. Written by Carole A Marxer and 5 co-authors. Institution: Hospital Pharmacy, University Hospital Basel, Basel, Switzerland. Major MEDLINE topics: Pregnancy Trimester, First, Teratogens, Abnormalities, Drug-Induced. Cited 5 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

Introduction

Exposure to potentially teratogenic medications during pregnancy is underinvestigated in Switzerland. We aimed to assess exposure to potential teratogens preconceptionally, during the first trimester, and in women of childbearing age, and specifically explore the effectiveness of the valproate pregnancy prevention program (2018). Material and Methods Retrospective study using the Swiss Helsana claims database. In a pregnancy cohort (2015–2021) and a cohort of women of childbearing age (2021 and 2018), we defined three 90‐day time periods: (1) first trimester, (2) preconceptional period (days 180–90 before pregnancy), and (3) January 01, 2021, and March 31, 2021 (women of childbearing age). During all periods, we quantified the exposure prevalence to at least one dispensed weak, proven, and unequivocally potent teratogen overall and by age strata. We quantified the exposure prevalence to each individual teratogen, and to valproate during pregnancy by calendar year to compare its use before and after the introduction of a pregnancy prevention program (2018). We investigated the use of systemic retinoids particularly isotretinoin in women of childbearing age.

Results

Of 34 584 pregnant women, 1.4% were exposed to potential teratogens during the first trimester (weak: 1.3%, proven: 0.06%, unequivocally potent: 0.04%). During the preconceptional period, 2.9% were exposed to any teratogen compared to 4.7% of women of childbearing age ( N total = 95 059). Systemic glucocorticoids were the most prevalent weak teratogens during all time periods (75% of all claimed teratogens during the first trimester). In the first trimester, the antibiotic cotrimoxazole and the thyreostatic thiamazole (weak teratogens), ranked second and third, followed by the antiseizure medications carbamazepine and topiramate (proven teratogens). Among women of childbearing age, exposure to weak and proven teratogens increased with age, whereas exposure to unequivocally potent teratogens decreased with age. This was due to 2.3% of women

Subjects

MeSH terms (MEDLINE)

Pregnancy Trimester, FirstTeratogensAbnormalities, Drug-InducedHumansFemalePregnancyRetrospective StudiesAdultSwitzerlandYoung AdultValproic AcidAnticonvulsants

Author keywords

Swiss healthcare datacongenital malformationsobservational researchpharmacoepidemiologypregnancysystemic retinoidsteratogensvalproate

Substances

TeratogensValproic AcidAnticonvulsants

Authors and institutions

  • Hospital Pharmacy, University Hospital Basel, Basel, Switzerland.
  • Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
  • Department of Health Sciences, Helsana Insurance Group, Zurich, Switzerland.
  • Department of Obstetrics and Gynaecology, University Hospital Bern, University of Bern, Bern, Switzerland.
  • Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
  • Service of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

ORCID profiles: Carole A Marxer, Daniel Surbek, Alice Panchaud, Christoph R Meier, Julia Spoendlin

Cite

APA

Marxer, C. A., Graber, S. M., Surbek, D., Panchaud, A., Meier, C. R., & Spoendlin, J. (2025). Exposure to potentially teratogenic medications before and during the first trimester of pregnancy compared to women of childbearing age: A retrospective analysis of Swiss claims data (2015–2021). Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.15052

Vancouver

Marxer CA, Graber SM, Surbek D, Panchaud A, Meier CR, Spoendlin J. Exposure to potentially teratogenic medications before and during the first trimester of pregnancy compared to women of childbearing age: A retrospective analysis of Swiss claims data (2015–2021). Acta Obstetricia et Gynecologica Scandinavica. 2025. doi:10.1111/aogs.15052

BibTeX
@article{Marxer2025,
  author = {Marxer, Carole A and Graber, Sereina M and Surbek, Daniel and Panchaud, Alice and Meier, Christoph R and Spoendlin, Julia},
  title = {Exposure to potentially teratogenic medications before and during the first trimester of pregnancy compared to women of childbearing age: A retrospective analysis of Swiss claims data (2015–2021)},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2025},
  doi = {10.1111/aogs.15052}
}
Start for free →